‚Äč

FREE COMMUNICATION 34


14:45-16:15   HALL C

Free Communication Session 34 + Mini Lecture

Glomerulonephritis: clinical and experimental 2

Chairs: Kathrin Eller, Graz, Austria
             Elion Hoxha, Hamburg, Germany

Mini lecture
Anti PLA2R antibodies and outcome of membranous nephropathy
Elion Hoxha, Hamburg, Germany

FREE COMMUNICATIONS

TO037
CLINICAL PREDICTORS OF RESPONSE TO RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS: A
EUROPEAN COHORT.
Federico Alberici1,2,3, Rona Smith2, Matthias Cassia1, Francesca Colombo1, Irene Brenna1, Rachel Jones2, Julia Holle4, Thomas Neumann5, Gina Gregorini6, Renato A. Sinico1, Annette Bruchfeld7, Iva Gunnarsson8, Sophie Ohlsson9, Bo Baslund10, Vladimir Tesar11, Zdenka Hruskova11, Maria Cid12, Augusto Vaglio13, Ken Smith2, David Jayne2, 1San Carlo Borromeo Hosp, Renal and Immunology Unit, Milano, ITALY, 2Univ Cambridge, Dept Medicine, Cambridge, UK, 3Univ Parma, Dept Experimental Medicine, Parma, ITALY, 4Klinikum Bad Bramstedt, Dept Rheumatology, Bad Bramstedt, GERMANY, 5Jena Univ-Hosp, Dept Internal Medicine III, Jena, GERMANY, 6AO Spedali Civili, Dept Nephrology, Brescia, ITALY, 7Karolinska Inst, Dept Renal Medicine, Stockholm, SWEDEN, 8Karolinska Inst, Dept Medicine, Stockholm, SWEDEN, 9Skane Univ Hosp, Dept Nephrology and Transplantation, Goteborg, SWEDEN, 10RigsHosp, Dept Infectious Diseases and Rheumatology, Copenhagen, DENMARK, 11Charles Univ, Dept Nephrology, Prague, CZECH REPUBLIC, 12Hosp Clinic, Vasculitis Research Unit, Barcelona, SPAIN, 13Univ Hosp Parma, Dept Nephrology, Parma, ITALY.

TO038 ASQ Travel Grant
TACROLIMUS WITH CORTICOSTEROIDS IS INFERIOR TO MODIFIED PONTICELLI REGIMEN IN
THE MANAGEMENT OF PRIMARY MEMBRANOUS NEPHROPATHY: RESULTS AT 2 YEARS OF
RANDOMIZATION

Raja Ramachandran1, Vinod Kumar1, Ritambhra Nada2, Harbir S. Kohli1, Vivekanand Jha1, Krishan L. Gupta1, 1PGIMER, Nephrology, Chandigarh, INDIA, 2PGIMER, Histopathology, Chandigarh, INDIA.

TO039
RISK OF VENOUS THROMBOEMBOLIC EVENTS IN ANCA ASSOCIATED VASCULITIS
Andreas Kronbichler1,2, Johannes Leierer1, Gisela Leierer3, Gert Mayer1, Alina Casian4, Peter
Höglund5, Kerstin Westman6, David Jayne2, 1Medical Univ Innsbruck, Nephrology and Hypertension,
Innsbruck, AUSTRIA, 2Addenbrooke’s Hosp, Vasculitis and Lupus Clinic, Cambridge, UK, 3Medical
Univ Innsbruck, Dept Dermatology and Venereology, Innsbruck, AUSTRIA, 4Guy’s Hosp, Louise Coote
Lupus Unit, London, UK, 5Skane Univ Hosp, Competence Center Clinical Research, Lund, SWEDEN,
6Skane Univ Hosp, Nephrology and Transplantation, Lund, SWEDEN.

TO040
A STAGING SYSTEM BASED ON GALECTIN3 FOR PREDICTION OF SURVIVAL IN SYSTEMIC IMMUNOGLOBULIN LIGHT CHAIN AMYLOIDOSIS WITH RENAL INVOLVEMENT

Ting Li1,2, Xianghua Huang1, Qingwen Wang1, Guisheng Ren1, Liang Zhao1, Shuiqin Cheng1, Zhi- Hong Liu1, 1National Clinical Research Center of Kidney Diseases, Jinling Hosp, Nanjing Univ School Medicine, Nanjing, CHINA, 2School Clinical Medicine, Southeast Univ, Nanjing, CHINA.

TO041
PROTEINURIA IS PREDICTING LONG TERM RENAL AND PATIENT OUTCOME IN ANCA ASSOCIATED
VASCULITIS.
Wladimir Szpirt1, Elizabeth Krarup2, Martin Egfjord1, 1RigsHosp, Nephrology, Copenhagen,
DENMARK, 2Herlev Hosp, Nephrology, Copenhagen, DENMARK.

 

back to the timetable

 

final programme "day by day" - may 21 - 24, 2016

today